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Mta, ~ the maternally transmitted antigen of mice, is a transplantation  antigen 
that can be detected by H-2-unrestricted CTL (1, 2). Mta has been found on all 
types of lymphoid  cells and  on  fibroblasts.  Three  genes are  required  for  the 
expression of Mta: Mtf, Hmt, and B2m,  The maternally  transmitted  factor, Mtf, 
is passed from mother to offspring via the egg (3) and is likely to be a mitochon- 
drial gene (4, 5). The Hmt gene has been mapped to the Tla region of the MHC 
on chromosome  17 (6). Since ~2-microglobulin (/32m) is required for expression 
of Mta (6, 7), 2 the product of the Hmt gene is most likely a class I MHC antigen 
located at the cell membrane. 
Until recently,  we had  identified only a  single  form of Mta, associated with 
Mtf  ~ and HmtL Mta(~,a) is found in >80 strains of laboratory mice. This antigen 
was absent in mice with Mt  H  or homozygous for Hmt b.  Wild mice from many 
different sources were also mostly Mta(a,a), but two possible variant forms were 
identified  among  WLA76  and  spretus  mice  (8).  Genetic  and  immunological 
analysis of WLA76 mice showed that their particular form of Mta is determined 
by a  new allele of the cytoplasmic gene, Mtp.  This led us to realize  that  each 
allele of Mtf (a,/3, 3/, etc.) determines a unique form of Mta. ~' 4 
Analysis of the spretus  Mta seemed particularly promising. Mus spretus is found 
in Southern  France,  Spain,  Portugal,  and  North  Africa (9).  Although  living in 
the same area as Mus musculus domesticus,  they do not readily interbreed,  even 
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in the  laboratory, and  they are  recognized as distinct  species (9-11).  A  variant 
form of Mta could be due to a change in any of the genes known to be involved 
in Mta expression. The mitochondrial genome of spretus  mice differs by at least 
8%  from  the  nucleotide  sequence  of domesticus  mitochondrial  DNA (12).  The 
/32m of spretus mice, determined by the B2m wl allele, is considerably more acidic 
than the fl2m of inbred  mice (13,  14).  Little is known about the MHC genes of 
Mus spretus. 
Materials and  Methods 
Nomenclature.  Alleles of Mtf are designated by Greek characters (a, /3,  7,  etc.) and 
alleles of Hmt by Roman characters (a, b, c, etc.). The Mta antigen of, say, an MtfHmt a/a 
cell will be designated Mta(/3,a), or (/3,a) for short. An MtffHmt ale cell has two Mta antigens, 
(a,a) and (a,c). The symbol a s will be used to indicate an Mtfderived from Mus spretus, 
even though it was indistinguishable in our tests from the a of old inbred strains. 
In all crosses, the female is listed first. Thus (B6 × SPE1) × B6 stands for (B6 2 × SPE1 
g) 9 × B6 ~. Alleles of heterozygous loci are listed in the order maternal/paternal. 
Mice.  Standard inbred strains were purchased from the Institut fiir Biologisch-Medi- 
zinische  Forschung,  Fiillinsdorf,  Switzerland;  GI.  Bomholtgaard,  Ry,  Denmark;  Olac, 
Ltd., Bicester, United Kingdom; and The Jackson Laboratory, Bar Harbor, ME. NMRI/ 
Han and NMRI/Bom are not inbred strains, but they are uniformly Mtf, and NMRI/ 
Bom is homozygous for H-2 n.  B10.CAS2  mice (abbreviated B.C2 in some tables) were 
bred at the  Basel Institute for Immunology from breeding pairs obtained  from Dr. J. 
Klein, Max Planck Institut f/Jr Biologie, Tfibingen. B6.AK1 breeding pairs were obtained 
from Dr. L. Flaherty, New York State Department of Health, Albany, NY. 
SPE1 is an inbred strain ofMus spretus, initiated from wild mice caught near Granada, 
Spain (F. Bonhomme, personal communication). It was received from the Pasteur Institute, 
Paris,  France  at  FIT and  again  at  F~j, and  then  maintained  in  Basel by brother-sister 
mating. Mus spretus  was established in  Liibeck (Lub) by random breeding in  a  closed 
colony from wild  mice caught near Porto Covo, Portugal  (15).  Mice carrying the  H-2 
complex of spretus/Lub  and Mtf  from NMRI/Han are designated  N.SPL.  ~Iice from 
closed colonies of Spanish (caught near Cadiz) and Moroccan spretus (caught near Azrou) 
were sent to us by Dr.  M.  Potter,  National Institutes of Health, Bethesda,  MD, who in 
turn had obtained these stocks from Dr. R. D. Sage, University of California, Berkeley, 
CA (16).  H-2 complexes from spretus/Spain  were backcrossed to C57BL/10 to give four 
lines, SPA1  (Mtf' from B10.CAS2) and N.SP1  (Mtf from NMRI/Bom) with H-2 sp~, and 
SPA2 (Mtf  ~) and N.SP2 (Mtf  °) with 14-2 sp2. 
Mice  are  being  made  congenic  for  mitochondrial  DNA  by  repeated  backcrossing, 
starting with a  female of one strain,  to males of another strain (8,  17).  Thus,  we have 
C57BL/6  (B6)  mice with mitochondrial  DNA from strain  NMRI/Bom (B6.Mtf,  previ- 
ously called NMB [2]),  WLA76 (B6.Mtp),  and  Moroccan spretus  (B6.mt'Pr).  The latter 
strain could be started only from a multiparous spretus female, since no viable offspring 
is obtained when virgin spretus mice are mated with laboratory males (11,  17). The mice 
used in the experiments were from the first up to the  13th generation of backcrossing. 
Similarly,  we  have  NZB/Bom  with  mitochondrial  DNA  of  strain  A.CA  (NZB.Mtff, 
previously  called  ANN  [2])  and  DBA/2  with  mitochondrial  DNA  of strain  WLA76 
(D2.MtfV).  DNM4 mice come from the fifth generation of backcrossing to NMRI/Bom 
males, starting with a DBA/2 female (8). 
Two stocks of wild mice were obtained from Dr. K. Moriwaki, National Institute for 
Genetics, Mishima, Japan; SUB-SHH is of the Mtf  ~ type, and BAC1 has the Hint d allele. 4 
C 3 H. R4 and B6. R9 mice have new recombinant M HC haplotypes derived from crossovers 
between H-2D (of C3H, and B6, respectively) and Hint (from M. m. castaneus);  the mice 
used in the present experiments were in the early stages of backcrossing. 
Breeding and Sampling.  All breeding was set up with one or two females to a male. To 
create H-2-congenic strains on the C57BL/10 background, inbred females were crossed 336  Mta  OF  SPRETUS  MICE 
with spretus  males,  but for all subsequent generations,  backcross females were mated to 
inbred males, as F~  males were always, and in subsequent generations frequently, sterile 
(11). 
At 5-7 wk of age, each mouse was sampled for typing (see below) by surgical removal 
of the spleen, a thymic lobe, or the cervical lymph nodes. Selected mice were mated when 
7-12 wk old. 
Mta Typing.  All typing for Mta was done in the killer cell assay. Donors of responding 
cells were immunized with at least three intraperitoneal  injections, 3 wk apart, of 15-20 
×  106 pooled spleen,  lymph node, and thymus cells in phosphate-buffered  HBSS. Bulk 
mixed  lymphocyte cultures  were  incubated  for  5  d.  The  killer  cells  were  assayed  in 
triplicate, at three concentrations (30, 10, and 3 ×  104) of responder cells cultured, against 
104 5~Cr-labeled target cells for three and one-half hours.  Cold-target competition was 
tested  in  duplicate  in  round-bottom  microtiter  plates  with  60,  30,  and  15  unlabeled 
competitors, and 30 initial responder cells per labeled target cell (8,  18). 
Three  strains  were  used  as  responders  against  Mta(a,a):  B6.Mtf  ~ was  primed  and 
boosted with B6,  129, or DDK cells (all H-2b); NZB/Bom or NZB/B1NJ with NZB.Mtff', 
NZB/Ibm, or B10.D2 cells (all H-2d); and NMRI/Bom with NMRI/Lac, DNM4, or SWR 
(all tt-2q).  In the  tables,  these  killer cells are  referred  to simply by their  H-2 types.  In 
competition tests, the labeled Mta(~,a) target cells always differed from the responder at 
H-2. 
The  target  cells  and  competitors  were  spleen  (and  occasionally  lymph  node)  cells 
cultured  for 2 d  with Con A  (2 #g/ml).  The blast cells were purified by centrifugation 
over a density cushion of Ficoll-Isopaque or simply washed in later tests. 
Results are given as percent specific 5'Cr release -- (experimental release -  spontaneous 
release) ×  100/(maximum release -  counter background) (19). Spontaneous release was 
usually 25-30% of maximum release, and the specific release carries an error of 1-2% in 
terms of the maximum release.  The tables show only the results obtained with 30 initial 
responders for direct killing and 60 competitors (unless otherwise indicated) for compe- 
tition tests; results at other cell concentrations were consistent with those shown. 
Long-term Lines.  The two killer cell lines used were (NMRI/Bom ×  B6)Fl anti-B6 and 
NZB/Bom  anti-NZB/Ibm.  Both  were  started  from  standard  bulk  mixed  lymphocyte 
cultures that were fed fresh medium on day 7 and  restimulated  with  irradiated  (3,000 
rad) antigen-bearing spleen cells (1 : 10 responder/stimulator ratio) on day 14 and day 21. 
The lines were then  maintained  by weekly stimulation  with antigen in medium supple- 
mented with T  cell growth factors (20% supernatant from Con A-stimulated rat spleen 
cells [20]). They were used 5 d  after the last restimulation at  10,  3, and  1, or 3,  1, and 
0.3 killers per target cell. The results shown are from the highest concentration tested. 
The two lines showed the same reactivity pattern on target cells from inbred strains. 
Mixed Lymphocyte Cultures.  To measure proliferation, mixed lymphocyte cultures were 
set up in flat-bottom microtiter plates with 5 x  105 lymph node responders and 5 x  10  ~ 
irradiated (1,750 rad) spleen cell stimulators per well, as described (2). The cultures were 
labeled overnight with 0.1 #Ci [SH]thymidine per well, and harvested on day 4. 
Serological  Typing.  To  characterize  the  spretus  H-2  haplotypes,  we  measured  the 
binding of a  panel of [3H]leucine-labeled mAb against H-2 and  Ia antigens to Con A- 
stimulated spleen cells (usually  1-2.5 x  106 per tube) as described (21). To type animals 
for breeding, their lymph node ceils were tested with one or two selected anti-H-2 and 
one or two anti-Ia antibodies, and thymocytes (5 and  10 X  106 per tube) were incubated 
with [3H]leucine-labeled mAb against TL, the marker most closely linked to Hint. 
Qa-2 typing was done by a  two-step complement-dependent  cytotoxicity assay, using 
mAb D3.262, specific for Qa-2 (22), and nylon wool-purified T  cells. 
Typing for 132m.  l-2 x  10 ~ Con A-stimulated lymph node or spleen cells were washed 
and incubated for 30 min at 37 °C with 50 #Ci [35S]methionine in 200 ~1 methionine-free 
RPMI  1640 medium.  The cells were lysed, and  the ~2m  was immunoprecipitated  and 
identified by SDS-PAGE or IEF (14). FISCHER  LINDAHL  ET  AL.  337 
Results 
All spretus mice we have assayed for Mta had the same characteristic phenotype 
(Table I). Anti-Mta(a,a) killers from a 5-d mixed lymphocyte culture always lysed 
spretus targets, though sometimes not as well as standard  Mta(a,a) targets. The 
same spretus targets were not lysed by our two killer cell lines specific for Mta(a,a), 
as shown  by the  appropriate  reactions  with  positive and  negative  controls  in 
Table I. Thus spretus cells have some crossreacting determinants that are covered 
by the more heterogeneous repertoire of the CTL from the fresh bulk cultures, 
but they lack the Mta epitope(s) recognized by the selected receptors of the long- 
term cultured lines.  It is therefore not surprising  that spretus cells cause no, or 
exceptionally weak, inhibition of Mta(a,a)-specific killing when used as competi- 
tors, even with fresh CTL (Table II). 
To define the  gene(s) responsible for the spretus  Mta phenotype,  we tested 
mice from a number of crosses (Table III). As it is conceivable that spretus mice 
have no Mta antigens at all, and that the observed killing was due to a crossreac- 
tion with H-2 or other class I antigens,  it is important to note that the lysis was 
retained  in  (B10.CAS2  x  spretus)Fl  hybrids,  which  are Mt~,  but  was  lost  in 
hybrids of NMRI mothers, which are Mtf  ~ (Tables III and IV). 
The  fact that  (B10.CAS2  X spretus)F~  hybrids display the spretus phenotype 
(Tables  I  and  II) suggests that  it is caused  by the Hmt allele of spretus,  to be 
defined as c.  These  hybrids have  the  common Mt~ and  the B2m b allele from 
C57BL/10 as well as B2m wl from spretus,  and they have inherited the immuno- 
logically silent Hmt b allele together with the castaneus  H-2 complex (6).  When 
the  hybrids were backcrossed to B10.CAS2,  the spretus  phenotype segregated 
together with the E, gene of the spretus H-2 complex, as would be expected of 
Hmt C, and independently of the spretus B2m wl allele (Table III). 
F1 hybrids of spretus males with NZB/Bom or NMRI females fully express the 
TABLE  I 
Lysis of Mus spretus Target Cells by mta(B,a) anti-mta(a,a) CTL 
Exp.  Target cell  H-2  Mta 
Percent specific 51Cr release 
by 
Fresh CTL  Long-term lines 
q  b  qxb  d 
896 
902 
951 
Spretus/Lub  ?  (a~,c)  44  37  0  -I 
A.CA  f  (a,a)  53  56  37  34 
SUB-SHH  ?  (6,a)  5  7  -3  2 
SPE1  sp3  (aLc)  24  30  0  -2 
N ZB.Mtp  d  (a,a)  49  47  17  37 
B6.mtf  a  b  (B,a)  14  1  0  0 
Spretus/Spain  ?  (a',c)  47  49  2  -- 
Spretus/Morocco  ?  (a',c)  50  51  0  -- 
C3H/HeJ  k  (a,a)  57  49  29  -- 
B10.CAS2  w17  (a,b)  8  3  0  -- 
(BI0.CAS2 x  SPE1)  wl7/sp3  (a,b/c)  48  46  -1  -- 
--, not done. 338  Mta  OF  SPRETUS  MICE 
TASTE  II 
Failure of Spretus Cells to Inhibit Mta(a,a)-specific Lysis 
Competitor  Mta  H-2 
Percent  specific 5~Cr release from 
labeled Mta(a,a) targets in Exp.: 
888  896  902  906  951  954 
None  --  --  49  57  28  52  48  49 
Spretus/Lub  (a~,c)  ?  37  51  .... 
SPE1  (a~,c)  sp3  --  --  21  39  --  -- 
Spretus/Spain  (a',c)  ?  ....  38  27 
Spretus/Morocco  (aS,c)  ?  ....  33  26 
A.CA  (a,a)  f  4  15  --  11  -- 
C3H/HeJ  (a,a)  k  --  -3  10  13 
NZB.Mtff  (a,a)  d  8  1  5  -- 
B6.Mtf  (/3,a)  b  --  --  23  45  40  -- 
NZB/Bom  (/3,a)  d  42  ....  41 
NMRI/Bom  (/3,a)  q  45  --  --  --  41  43 
(NMR1  ×  WLA)F,  (/3,a)  q/?  --  55  .... 
B10.CAS2  (a,b)  w17  ....  42  -- 
(B10.CAS2  x  SPE1)F~  (a,b/c)  wl7/sp3  ....  34  37 
--,  not done.  Significant inhibition marked  by box. 
Mta(/3,a)  antigen,  as evident by direct  killing  (Table  IV) and  competition  (not 
shown), a  result consistent with codominant expression of Hmt alleles.  Hybrids 
backcrossed  to  B10.CAS2  males  either  expressed  a  normal  Mta(/3,a)  antigen 
together  with  the  H-2  of the  NMRI/Han  grandmother,  or  they  were  killed 
neither  by anti-(/3,a)  nor  by anti-(a,a)  CTL.  Among  18  Mtf  ~ backcross  mice 
tested, there  was one recombinant  between the E~ and  the Hmt  loci (unfortu- 
nately discovered too late to be tested for other markers on chromosome  17). 
Together  with  12  Mt  F  backcross  mice  studied,  this  gives  a  recombination 
frequency of 1 in  30,  consistent with previous mapping  of Hmt  2.0  +  1.2  cM 
distal to H-2D (6).  Again, the B2m wl allele had no effect on the Mta phenotype. 
The maternally transmitted factor ofMus spretus was tested separately in mice 
from the fourth to the eighth  generation  of backcrossing the descendants of a 
Moroccan  spretus  female  to  C57BL/6  males.  These  mice  have  retained  the 
spretus  mitochondrial  DNA (17),  but they were non-agouti,  suggesting  loss of 
B2m ~'~, which is linked to the A w  allele (14), and they were negative for serological 
markers associated with spretus  H-2.  The  mice expressed an  Mta(a,a)  indistin- 
guishable,  within  the limits of the assays, from that of standard  C57BL/6 both 
in direct killing and in competition (Table V).  Analysis of the very donors for 
these tests confirmed that they carried spretus mitochondrial  DNA (M. Hirama 
and M. Phillips,  personal communication).  Thus, spretus mice seem to have the 
common  Mt~  allele  carried  by  B6,  despite  the  marked  (8-17%)  nucleotide 
sequence divergence from B6 mitochondrial  DNA (12). 
If spretus mice have a new allele of Hmt,  it should be possible to raise killers 
specific for the  Mta determined  by this  allele,  using the  King  Lear  scheme of 
immunization.  We bred F1 hybrids from B6.Mtf  ~ females and males of the inbred FISCHER  LINDAHL  ET  AL.  339 
TABLE  1II 
Phenotype of Spretus Progeny Tested with CTL Specific  for Mta(a,a) and Mta([3,a) 
Genotype  Number  Mta phe- 
Cross (~ x  c~) 
Mtf  Hmt*  H-2  B2m  tested (n)  notype 
Bl 0.CAS2 x  Spretus/Spain  a  b/c  w17/sp1  b/w1  4  Spretus 
w17/sp2 
B10.CAS2 x  SPEI 
(BI 0.CAS2 x  SPE1) x 
(B10.CAS2) 
a  b/c  w17/sp3  b/wl  6  Spretus 
a  c/b  sp3/wl7  wl/b  1  Spretus 
c~  c/b  sp3/w 17  b/b  1  Spretus 
a  b/b  w17/w17  wl/b  9  Blank 
a  b/b  w17/w17  b/b  1  Blank 
NZB/Bom X SPE1  13  a/c  d/sp3  a/wl  3  NZB* 
NMRI/Bom x Spretus/Spain  13  a/c  q/spl  a/wl  3 
q/sp2 
NZB 
NMRI/Han x Spretus/Lub  13  a/c  ?/sp4  a/w l  3  NZB 
(NMRI/Han x Spretus/Lub)  X  13  c/b  sp4/wl7  wl/b  5  Blank 
B10.CAS2  3  c/b  sp4/wl7  a/b  3  Blank 
13  cg/b  ?/w17  wl/b  1  Blank 
13  a/b  ?/w17  wl/b  4  NZB 
13  a/b  ?/w17  a/b  5  NZB 
* Hmt genotype inferred from E~ phenotype. 
* Like cell  from of NZB mice, these cells are killed (see Table IV) and completely inhibit lysis of 
labeled NZB target cells by anti-Mta(13,a) CTL. 2 
§ This mouse is presumed to be a recombinant between E~ and Hmt. 
SPE1 strain.  Such F1 daughters were then immunized with cells from the father 
and other male SPE1  donors;  the H-2 b haplotype allowed the F~  to respond to 
the male antigen, H-Y, as a helper determinant (23). Immune FI cells were then 
restimulated  in  vitro  with  SPE1  female  cells,  which  should  differ  from  the 
Mta(/3,a/c)  F~  only by the  Mta(a,c)  antigen,  all  other  SPE1  histocompatibility 
antigens  being  codominantly  expressed  in  the  F~.  Table  VI  shows that  CTL 
raised in this manner  kill all (a,c) target cells independently of H-2; they fail to 
react with (~,b), (3,c), or (6,a) target cells, but react weakly with (a,a), ('y,a), and 
(a,d) target cells. The lysis of SPE1  target cells can be efficiently inhibited only 
by (a,c) competitors, and it does not matter whether the Mtfof these is derived 
from spretus or laboratory mice (Table VII). There is an indication that Mta(a,c) 
is expressed less efficiently by Hmt  a/c cells [which also express Mta(a,a)] than by 
Hmt b/c cells (which are not known to express a second form of Mta). 
The F~ anti-SPE1  killers are not restricted by an H-2K or -D molecule. They 
reacted  equally  well  with  all  (o~,c) targets,  irrespective  of whether  their  H-2 
complex came from SPE1  or from spretus/Spain  (mice with  H-2 from spretus/ 
Lub were not available for testing at the time of the experiments). Mice with the 
four spretus  H-2  hapiotypes  that  we are  now  backcrossing onto a  C57BL/10 
background (with either Mtf  ~ or Mtf) all  differ serologically (Table VIII) and 340  Mta  OF  SPRETUS  MICE 
TABL~  IV 
Effect of Spretus Hmt" on Lysis by anti-Mta([3,a)  CTL 
Target cells  H-2*  Mta*  B2m 
Percent specific S~Cr re- 
leased by CTL* 
(a,a)  (y,a)  (/3,a) 
Anti-  Anti-  Anti- 
(/3,a)  (3,a)  (a,a) 
NMRI/Bom  q  (/3,a) 
DNM4  q/(d?)  (o~,a) 
B10.CAS2  w17  (a,b) 
(B10.CAS2 X Spretus/Spain)Fa  w17/spl/2  (o~,b/c) 
Spretus/Spain 
(NMRI/Bom X Spretus/Spain)Fl  spl/2  (~,c) 
q/spt/2  (¢La/c) 
1  ?/w 17  (3,a/b) 
2  ?/w17  (~,a/b) 
3  ?/w 17  (3,a/b) 
4  sp4/w 17  (O,c/b) 
5  sp4/wl7  (3,c/b) 
6  sp4/w 17  (3,c/b) 
(NMRI/Han x  Spretus/Lub)  × 
B10.CAS2 
a  46  55  4 
a  6  8  44 
b  5  6 a  5 
b/wl  -8  -6  19 
wl  6  9  25 
a/w1  44  50  1 
a/b  28  34  -3 
wl[b  32  39  -2 
wl/b  32  34  -3 
a/b  6  0  -2 
wl/b  10  1  -2 
wl/b  8  -1  -4 
* Backcross  mice  were  typed  for  E,,  and  H-2  and  Hmt 
Spretus/Spain  may have been H-2  ~pl or H-2  sp2. 
* c~ Anti-/3, B6 anti-B6.Mtfa; 3' anti-3, B6.Mt.p anti-B6.Mtff; 
a Effector/target ratio of 10:1, all others 30:1. 
types  were  inferred  from  the  results. 
and/3 anti-a, B6.Mt~ anti-B6. 
TABLE  V 
Comparison of Mtf of Mus spretus with Mtf" of B6 Mice 
Competitor  Mtf  Hint  H-2 
Percent specific 51Cr release from labeled 
Mta(a,a) target cells in Exp.: 
998  1002  1004  1006  1137 
b*  b  b  d  d  b  d 
None  --  --  --  31  45  46  60  55  38  35 
C3H/HeJ or AKR  a  a  k  --  3  29  16  3  -4 
B6.mO  w  a ~  a  b  13  12  27  21  6  8 
SPE1  a ~  c  sp3  10  --  25  54  --  24  26 
B10.CAS2 x  SPEI  a  b/c  w17/sp3  14  30  32  63  26 
B6.Mtf  n  13  a  b  --  34  48  24  21 
NMRI X Spretus  /3  a/c  q/sp  16  --  36  60  46  27  21 
--, not done. Significant inhibition marked by box. 
* H-2 type of Mta(3,a) anti-Mta(c~,a) CTL. 
all  stimulate  each  other  in  mixed  lymphocyte  cultures  (Table  IX).  SPE1  is 
negative  for Qa-2,  and  it expresses  the  a  allele of Qa-1 as measured  with specific 
killers  in  a  competition  test  (18,  24).  All  four  spretus  haplotypes  bind  the  anti- 
TL  mAb,  18/20,  at a  level comparable  to BALB/c  (21). FISCHER  LINDAHL  ET  AL.  341 
TABLE  VI 
Specificity of Killing by (B6.mtf  a x  SPE1)F~ anti-SPE1 CTL 
Percent  specific 51Cr release in 
Target  Mtf  Hint  H-2  Exp.: 
1102  1122  I129  1137  1138 
SPE1  a'  c  sp3  46  55  51  41  53 
(B.C2 X  SPE)  X  B.C2  ct  c/b  sp3/wl7  60  .... 
(B.C2 ×  SPAI)FI  a  b/c  wl7/spl  --  --  --  45  23 
(B.C2  ×  SPA2)F]  a  b/c  wl7/sp2  --  47  46  --  -- 
(N.SP2  X  B.C2) X  B.C2  /3  c/b  sp2/wl7  ..... 2 
B6.mt wr  a'  a  b  --  25  29  18  -- 
B6  a  a  b  46  --  --  21  -- 
CBA  or C3H  a  a  k  --  26  12  14  -- 
B6.Mtf v  "y  a  b  --  18  --  --  -- 
D2.Mtf v  "y  a  d  43  .... 
B.C2  X  (B.C2  X  BAC1)  a  bid  w17/?  --  --  20  --  -- 
B10.CAS2  a  b  w17  9  .... 
C3H.R4  ot  b  k  --  --  5  0  -- 
B6.R9  a  b  b  --  18  ~  1  -- 
B6.Mtf ¢  /3  a  b  3  --  --  0  -- 
NMRI/Bom  /3  a  q  --  6  3  -1  -- 
(SUB-SHH  X  B.C2)Fj  ~  a/b  ?/w17  --  --  -8  0  -- 
--,  not done 
Discussion 
Mus spretus  has a  unique  Mta  phenotype that  crossreacts  with  the  standard 
Mta(a,a) antigen, and spretus mice do not carry the common Hmt a allele. A gene 
closely linked  to  the  H-2  complex  and  associated with  at  least  four different 
spretus H-2 haplotypes is responsible for the spretus phenotype. We define it as a 
new allele, c, of Hmt. 
CTL usually recognize the outer two domains of class I antigens (25-28), and 
killers specific for aliogenic H-2 antigens are not affected by allelic differences 
of/32m (29). Thus, it is not surprising that the B2m wl allele of spretus mice had 
no effect on the Mta phenotype. The surprise was that  the Mtfallele of spretus 
proved indistinguishable from the Mt~ of old inbred strains. 
Since Mtfis associated with mitochondrial DNA both in population studies  s (4) 
and in somatic cell hybrids (5, 30), Mtf is presumed to be a mitochondrial gene. 
In  view of the  estimated  8-17%  nucleotide  sequence divergence between the 
mitochondrial  DNA of spretus and laboratory mice (12), some antigenic differ- 
ence  was to be expected,  but  none  was found.  We have  tried  to  raise  killers 
directly in B6.mt  w~ mice against standard  B6, of which they should be tolerant 
apart  from determinants  encoded in  mitochondrial  DNA or other maternally 
inherited  genes.  A  response could actually be obtained, but the specificity has 
remained variable and obscure. 
The  maternally  transmitted  factor, Mtf,  contributes to the  epitopes of Mta, 
and four different forms have been defined to date. 3' 4 If Hmt only determined 
the amount of Mta expressed (a, high; b, none; c ~< d, intermediate),  then killers 
raised in Mta(/3,a/c) mice against Mta(a,c/c) reacting with the homologous target 
should  be completely inhibited  by Mta(ot,a/a)  competitors,  as  these  expressed 342  Mta  OF  SPRETUS  MICE 
TABLE  VII 
Cold-target Inhibition of Lysis of Labeled SPE I  Targets by 
(B6,Mtf ~ × SPE1)FI Anti-SPE1 CTL 
Competitor*  Mtf  Hmt  H-2 
Percent specific ~Cr 
release in Exp.* 
1122  1129  1137  1138 
None 
SPE1  or*  c  sp3 
(B.C2 ×  SPA1)F~  a  b/c  wl7/spl 
(B.C2 ×  SPA2)F1  a  b/c  wl7/sp2 
(B.C2 ×  SPE) ×  B.C2  a  c/b  sp3]w17 
(B.C2 ×  SPA1) ×  B10.HTG  a  c/a  spl/g 
([B.C2 ×  SPAI] x  B.HTG) ×  B10  a  c/a  spl/b 
N.SP1  ×  BI0  13  c/a  spl/b 
N.SP2 ×  B.C2  13  c/b  sp2/wl7 
B6.mt  w"  a*  a  b 
B6  a  a  b 
NMRI/Lac  a  a  q 
B6.Mtf~  ~  a  b 
NMRI/Bom  13  a  q 
B6,Mtf  ~  3'  a  b 
B.C2 ×  (B.C2 ×  BACI)  a  b/d  w17/? 
B10  x  (B.C2 x  [B.C2 x  BACI])  a  a/d  w17/? 
B10.CAS2  a  b  w17 
B6.R9  a  b  b 
(SUB-SHH X B.C2)FI  6  a/b  ?/w17 
54  58  44  50 
12  15  5  9 
--  --  4  6 
8  13  2  -- 
--  9  2  -- 
--  --  --  17 
--  31  --  -- 
--  62  39  46 
51  60  36  46 
45  53  --  -- 
46  54  37  -- 
46  --  31  42 
--  52  35  -- 
50  --  39  -- 
51  --  36  -- 
--  56  --  -- 
--  --  --  41 
--  --  37  -- 
48  54  36  -- 
--  49  39  -- 
* Competitor/target ratio was 30:1  in Exp.  1137, and 60:1  in all  others. 
* --  not done. Significant inhibition marked by box. 
more of the  same antigen.  Instead,  such  killers  showed strong  preference  for 
Mta(c~,c) targets. A ready interpretation of this result is that Hrat also contributes 
to the specificity of Mta, which is therefore determined jointly by Mtfand Hint. 
Without an appropriate  recombinant,  we cannot  iormalIy exclude the possi- 
bility that  the  killers  specific for  Mta(a,c)  recognize  an  H-2K or -D molecule 
shared  by all  the  spretus  haplotypes.  However, this  seems unlikely for  several 
reasons. The four hapiotypes we have studied clearly differ by at least one H-2 
and one Ia molecule, as shown by the strong mixed lymphocyte responses (Table 
IX), the serological differences (Table VIII), and the inability to crosscompete 
for  anti-H-2  killer  ceils  (data  not  shown).  Furthermore,  the  spretus  Mta,  like 
Mta(a,a), is easily detected on thymocytes, which have very little H-2. 
The  requirement  for 82m  as well as the  location of Hint in  the  Tla region 
suggest that Hint encodes a class I MHC antigen; this antigen then interacts with 
the product of the Mtfgene to create Mta. Thus, Mta would structurally resemble 
the  target antigens  created by interaction  of viral  or minor  histocompatibility 
antigens and H-2. Even though this would be the first example in the mouse of 
a class I antigen other than  H-2K, -D, or -L forming a self-plus-X determinant, 
such a case has been described in the rat by Livingstone and her colleagues (cited 
in  31).  There,  X  is  a  minor  histocompatibility  antigen  showing  Mendelian FISCHER  LlNDAHL  ET  AL. 
TABLE  VIII 
Preliminary Serological Characterization of Four Mus spretus H-2 
Haplotypes Under Inbreeding 
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mAb  Reference  Immunizing 
specificity 
Spretus line (H-2) 
SPA1  SPA2  SPE1  SPL 
(spl)  (sp2)  (sp3)  (sp4) 
10-3.6  32  I-A  k  -*  +  +  + 
H8.15.9  33  I-A  k  +  -  +  - 
14-4-4  34  E~  +  +  +  + 
B8-24-3  35  K u  NT  NT  -  - 
H141-30  36  D b  NT  NT  -  - 
B??  --*  ?  NT  NT  -  - 
31-3-4  37  K a  .... 
34-2-12  37  D d  .... 
34-4-21  37  D d  -  -  -  + 
34-7-23  37  D a  +  +  +  NT 
28-14-8  38  L a  -  NT  -  - 
H  100-5/28  36  K k  +  -  +  - 
H 100-27/55  36  K k  -  -  +  - 
H 100-30/23  36  K ~  +  NT  -  NT 
H 116-22/7  36  K k  +  NT  +  - 
H 142-45  36  K k  -  -  -  _+ 
3-83  34  K k  _  -  -  + 
12-2-2  34  K k  +-  +  +  + 
15-1-5  34  K ~  +  -  +  + 
15-3-1  34  K k  .... 
15-5-5  34  K k  .... 
16-1-2  34  K k  -  -  +  - 
D3.262  22  Qa-2  NT  NT  -  NT 
18/20  36  Tla  a  +  +  +  + 
*  NT,  not tested; -,  negative, +, weakly positive, +, positive. 
* Hybridoma  of  unknown  origin,  received  under  a  false  name,  which  secretes  IgM  specific  for 
H-2D g and H-2D  q. 
TABLE  IX 
Mixed Lymphocyte Culture Responses among Four Spretus Haplotypes 
Responder cells  H-2 
BI0.CAS2 
[SH]Thymidine  uptake  (median  cpm X 1O  -s) with stimulator cells from: 
SPEI  (B.C2 x  SPAI)FI  (B.C2 x  SPA2)FI  N.SPL × B.C2  B6.AKI 
BIO.CAS2  w17  2,8  17.3  15.7  16.6  14.5  14.6 
(BI0.CAS2 × SPE1)FI  w17/sp3  2...33  2.4  14.6  12.4  9.0  10.5 
(BI0.CAS2 × SPA1)FI  w17]spl  1.7  21.6  2.0  26.4  22.5  9.0 
(BI0.CAS2 X SPA2)FI  wl7/sp2  1.9  16.7  18.0  1.5  17.8  14.9 
N.SPL X BI0.CAS2  sp4/w17  1.8  8.0  1 1.9  12.0  2.6  7.8 
B6.AK1  akl  8.8  16.0  19.9  1 1.0  1 1.9  2.5 
Responses to H-2-compatible cells (negative controls) are underscored. 
inheritance,  and  the  restricting  element  has  been  mapped  to  the  RT1.C  region. 
The  formation  of  such  complexes  between  class  I  MHC  antigens  of  the  Qa/Tla 
regions  and  other  cellular  proteins  may  be  a  general  phenomenon  that  has 
escaped  detection  for  lack  of  polymorphism  of  the  molecules  involved. 344  Mta  OF  SPRETUS  MICE 
Summary 
Mus spretus  from four stocks,  originating  in  Spain,  Portugal,  and  Morocco, 
were tested for the maternally transmitted antigen, Mta. All expressed a variant 
form not  found in  other species  of mice.  Analysis of appropriate  crosses with 
inbred mice showed that the spretus form of Mta is determined by a new allele, 
c,  of the  Hmt  gene.  The Hmt  c allele  has  been  isolated  in  coupling  with  four 
different H-2 haplotypes. It is possible to raise CTL specific for the spretus form 
of Mta. The maternally transmitted factor, Mtf  ~s, of spretus mice determines, in 
conjunction with the Hmt a allele of C57BL/6, an  Mta  that  is  indistinguishable 
from the common  form found in  C57BL/6 and  most other inbred mice.  Our 
experiments show that the specificity of the cell surface antigen Mta is governed 
jointly by the cytoplasmic gene Mtfand the chromosomal gene Hmt.  We propose 
that Hmt encodes a  class  I  histocompatibility antigen  that  acts as  a  restricting 
element for the Mtfgene product, thus meeting the requirements of T  killer cell 
recognition. 
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